Trial news: The AGITG currently has eleven studies open to recruitment and five studies in follow up.
The table below details the trials that are currently accruing patients.
| Recruited | Target | |
| ACTICCA-1 | 5 | 50 |
| ASCOLT | 321 | 400 |
| DYNAMIC-III | 97 | 1000 |
| DYNAMIC-Rectal | 15 | 408 |
| INTEGRATE II | 39 | 90 |
| LIBERATE | 50 | 100 |
| MODULATE | 24 | 90 |
| MONARCC | 4 | 80 |
| NABNEC | 26 | 70 |
| SPAR | 6 | 222 |
| TOP GEAR | 204 | 280 |
Recruitment figures are for Australian and New Zealand sites as at end November 2018.
Trial Results Lay Summaries (click on the links below):
ALaCaRT
ATTACHE
ATTAX-3
GAP
ICECREAM
INTEGRATE
TACTIC
TOP GEAR
CO.17
EORTC 62024
Advanced GIST